Table 1 Absolute difference and ranking according to blood glucose level
From: The optimal glycemic target in critically ill patients: an updated network meta-analysis
Hospital mortality | 28- or 30-day mortality | Long-term mortality | Infection | Hypoglycemia | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Absolute difference (95% CrI) | Rank (SUCRA) | Absolute difference (95% CrI) | Rank (SUCRA) | Absolute difference (95% CrI) | Rank (SUCRA) | Absolute difference (95% CrI) | Rank (SUCRA) | Absolute difference (95% CrI) | Rank (SUCRA) | |
vs < 110 mg/dL | ||||||||||
< 110mg/dL | No estimable | 3 (47.4) | No estimable | 2 (49.7) | No estimable | 4 (34.2) | No estimable | 3 (42.4) | No estimable | 4 (14.3) |
110–144 mg/dL | 15 fewer per 1000 (73 fewer to 70 more) | 2 (65.9) | 40 more per 1000 (88 fewer to 198 more) | 4 (28.9) | 14 fewer per 1000 (123 fewer to 159 more) | 2 (55.3) | 35 fewer per 1000 (82 fewer to 27 more) | 1 (87.4) | 14 fewer per 1000 (90 fewer to 273 more) | 3 (21.6) |
144–180 mg/dL | 16 fewer per 1000 (79 fewer to 38 more) | 1 (68.6) | 11 fewer per 1000 (40 fewer to 19 more) | 1 (78.3) | 15 fewer per 1000 (48 fewer to 18 more) | 1 (70.1) | 13 fewer per 1000 (44 fewer to 20 more) | 2 (69.0) | 69 fewer per 1000 (79 fewer to 49 fewer) | 1 (82.1) |
> 180 mg/dL | 10 more per 1000 (13 fewer to 42 more) | 4 (18.0) | 4 more per 1000 (34 fewer to 50 more) | 3 (43.1) | 1 fewer per 1000 (19 fewer to 21 more) | 3 (40.4) | 31 more per 1000 (4 more to 68 more) | 4 (1.2) | 48 fewer per 1000 (54 fewer to 39 fewer) | 2 (81.9) |
vs 110–144 mg/dL | ||||||||||
144–180 mg/dL | 4 more per 1000 (96 fewer to 120 more) | 43 fewer per 1000 (135 fewer to 83 more) | 1 more per 1000 (59 fewer to 122 more) | 29 more per 1000 (58 fewer to 131 more) | 65 fewer per 1000 (81 fewer to 9 more) | |||||
> 180 mg/dL | 38 more per 1000 (53 fewer to 151 more) | 28 fewer per 1000 (122 fewer to 99 more) | 8 more per 1000 (56 fewer to 130 more) | 109 more per 1000 (19 more to 218 more) | 28 fewer per 1000 (35 fewer to 10 more) | |||||
vs 144–180 mg/dL | ||||||||||
> 180 mg/dL | 2 more per 1000 (1 fewer to 8 more) | 1 more per 1000 (1 fewer to 4 more) | 13 more per 1000 (23 fewer to 57 more) | 26 more per 1000 (4 more to 61 more) | 0 fewer per 1000 (6 fewer to 16 more) | |||||
Acute kidney injury | ||
|---|---|---|
Absolute difference (95% CrI) | Rank (SUCRA) | |
vs < 110 mg/dL | ||
< 110 mg/dL | No estimable | 2 (46.7) |
110–144 mg/dL | 34 fewer per 1000 (64 fewer to 27 more) | 1 (89.8) |
144–180 mg/dL | 10 more per 1000 (66 fewer to 184 more) | 3 (36.6) |
> 180 mg/dL | 8 more per 1000 (23 fewer to 52 more) | 4 (27.0) |
vs 110–144 mg/dL | ||
144–180 mg/dL | 118 more per 1000 (82 fewer to 473 more) | |
> 180 mg/dL | 120 more per 1000 (17 fewer to 324 more) | |
vs 144–180 mg/dL | ||
> 180 mg/dL | 0 more per 1000 (67 fewer to 164 more) | |